Valantine Hannah 4/A
4/A · BridgeBio Pharma, Inc. · Filed Jun 30, 2025
Insider Transaction Report
Form 4/AAmended
Valantine Hannah
Director
Transactions
- Purchase
Common Stock
2021-12-28$13.16/sh+796$10,475→ 2,687 total(indirect: By Spouse) - Purchase
Common Stock
2021-12-28$12.68/sh+1,542$19,553→ 1,542 total